艾普斯坦-巴尔病毒感染的桃体边缘区域B细胞in vivo作为免疫抑制相关的B细胞淋巴瘤的前体
Charles Torgbor1, David A Thorley-Lawson1, Ann M Moormann2
1Tufts University School of Medicine, Boston, Massachusetts, USA.
Journal of virology
|July 8, 2025
概括
爱斯坦-巴尔病毒 (EBV) 感染边缘区域B细胞,建立一个新的GC独立的持久性途径. 这些感染了EBV的MZ B细胞是免疫芽细胞淋巴瘤 (IL) 的前体,并提供治疗点.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 持久性主要由生殖中心模型 (GCM) 解释,其中EBV感染了天真B细胞,并在记忆B细胞中建立了终身感染.
- 虽然GCM解释了EBV相关的癌症,但免疫抑制相关的/免疫芽细胞B细胞淋巴瘤 (IL) 的正常*in vivo*对应物仍然未被确定.
- IL类似于体外的淋巴细胞细胞系 (LCL),这些细胞系是感染了EBV的B细胞,具有不受控制的增殖.
研究的目的:
- 通过对人类桃体B细胞进行比较分析,确定ILs/LCLs的正常*in vivo*对应物.
- 阐明与IL发展相关的EBV持久性路径.
主要方法:
- 对人类桃体B细胞进行比较分析.
- 用关键标志物和扩散状态来表征EBV感染边缘区 (MZ) B细胞的特征.
主要成果:
- 独立于生殖中心的EBV感染的桃体MZ B细胞是ILs/LCLs最接近的*in vivo*相关细胞.
- 这些细胞表现出EBV生长程序,包括高瘤性LMP1和AID的表达,在BCL6.6缺席的情况下.
- 感染了EBV的MZ B细胞表现出广泛的增殖 (Ki67+),并且由于AID,增殖和LMP1表达,患瘤发展的风险很高.
结论:
- 除了GCM,还提出了EBV持久性的第二个途径,即GC独立的MZ模型.
- 感染了EBV的MZ B细胞是IL的可信的*in vivo*前体.
- 在这些细胞中准LMP1为IL提供了潜在的治疗策略.
相关概念视频
Cells of the Adaptive Immune Response
4.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.5K
B Cell Activation and Differentiation
6.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.5K


